Curaleaf Holdings (CURLF) Amortizatization of Intangibles (2022 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Amortizatization of Intangibles of $3.7 million in Q4 2024, up 20.32% quarter-over-quarter from $3.1 million in Q3 2024, and down 12.15% on a YoY basis from $4.2 million in Q1 2024.
Curaleaf Holdings (CURLF) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends
Curaleaf Holdings' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $3.7 million for Q4 2024.
- In Q4 2024, Amortizatization of Intangibles fell 12.15% year-over-year to $3.7 million; the TTM figure through Dec 2024 stood at $15.1 million (changed N/A YoY), while the FY2025 annual figure was $19.4 million, up 17.39% from the prior year.
- Amortizatization of Intangibles was $3.7 million for Q4 2024 at Curaleaf Holdings, up from $3.1 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4.2 million in Q4 2023 to a low of $636000.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $3.1 million across 3 years, with a median of $3.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles surged 561.32% in 2023, then fell 25.59% in 2024.
- A 3-year view of Amortizatization of Intangibles shows it stood at $636000.0 in 2022, then soared by 561.32% to $4.2 million in 2023, then dropped by 12.15% to $3.7 million in 2024.
- The last three Amortizatization of Intangibles figures came in at $3.7 million (Q4 2024), $3.1 million (Q3 2024), and $4.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 242,000.00 |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Dec 31, 2022 | 636,000.00 |
| Dec 31, 2022 | 636,000.00 |